Semaglutide 5mg Vial
$115.00
Product Overview
Semaglutide 5mg is a next-generation GLP-1 receptor agonist designed to support glycemic control and weight management. Packaged in a 2 mL vial as a lyophilized powder, this formulation is ideal for clinical and research applications focused on type 2 diabetes and obesity treatment.
Key Features
- Active Ingredient: Semaglutide (5mg per vial)
- Form: Lyophilized powder for subcutaneous injection
- Presentation: 5 vials × 1mg or single 5mg vial with bacteriostatic water (2 mL)
- Storage: Refrigerate at 2–8°C
- Purity: ≥99% pharma-grade, endotoxin-free
Mechanism of Action
Semaglutide mimics the GLP-1 hormone, enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. These effects contribute to improved blood sugar regulation and reduced appetite, making it a powerful agent for metabolic intervention.
Clinical Benefits
- Supports glycemic control in type 2 diabetes
- Promotes sustainable weight loss
- Reduces cardiovascular risk factors
- Enables once-weekly dosing due to extended half-life
Usage Guidelines
- Initial Phase: Start with 0.25–0.5 mg weekly
- Titration: Gradually increase based on tolerance
- Maintenance: Typically 1 mg weekly, adjusted per patient response
- Administration: Subcutaneous injection; reconstitute with bacteriostatic water to 1 mg/mL
Safety & Monitoring
- Common side effects: nausea, vomiting, diarrhea, mild GI discomfort
- Rare risks: hypoglycemia (especially with other antidiabetic agents), pancreatitis, gallbladder issues
- Regular monitoring of blood glucose is advised
Packaging:
- Supplied in sterile, medical-grade vials for secure storage and accurate dispensing
Compliance Notice:
- For laboratory research use only
- Not for human or veterinary consumption